FindTrial
Sign In

a retrospective cohort study at a tertiary centre in India to study Effect of Anti- SSA/Ro and Anti SSB /La antibodies on obstetric and perinatal outcomes â??

Effect of Anti- SSA/Ro and Anti SSB /La antibodies on obstetric and perinatal outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041676
Enrollment
40
Registered
2022-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O359- Maternal care for (suspected) fetal abnormality and damage, unspecified

Interventions

None listed

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Anti -Ro/anti-La antibodies positive pregnant women 2)Age more than 18 years

Exclusion criteria

Exclusion criteria: 1) Pregnancies occurring before diagnosis of disease

Design outcomes

Primary

MeasureTime frame
To assess Obstetric and perinatal outcomes in women with anti-Ro/anti-La positive antibodies . Neonates with Heart block, neonatal lupus at full term IUGR , Oligo amnios, doppler changes before term Medical termination of pregancy in first trimester Timepoint: First TRrimester pregnancy for fetal loss Third trimester for preterm After delivery for Neonatal outcomes—

Secondary

MeasureTime frame
NilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Rajashree Menon

Amrita Institute of Medical Sciences

drrajashreemenon@gmail.com09495941973

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026